EMERGING PUBLIC BIOTECH

PACIRA BIOSCIENCES INC (PCRX)

Brisbane, United States · North America
EMERGING PUBLIC BIOTECH
HEADQUARTERS
Brisbane, United States
TICKER
PCRX
SEGMENT
Emerging Public Biotech
THERAPY AREAS
KEY PRODUCTS
PRODUCTDETAILS
Exparel liposomal
DepoCyte
COMPANY OVERVIEW

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also develops PCRX-201, a novel gene therapy vector platform enabling local administration of genetic medici…

PACIRA BIOSCIENCES INC — FULL INTELLIGENCE

Live regulatory signals, patent cliffs, financials, tariff exposure and pipeline — all free on PharmaSignal.

OPEN PLATFORM →